Q&As on Depression
Welcome to our dedicated Q&A section on depression, where we bring together a diverse panel of experts from within and outside our consortium to address some pressing and intriguing questions. Whether you are seeking insights on the latest research, treatment options, coping strategies, or understanding the complexities of depression, our experts are here to provide evidence-based, compassionate, and informative answers. This section is designed to be a supportive resource for anyone looking to deepen their understanding of depression and find practical advice to navigate its challenges.


Assoc. Prof. Jakub Kazmierski, MD, PhD
Head of The Department of Old Age Psychiatry and Psychotic Disorders,
Faculty of Gerontology, Medical University of Lodz, Poland
​
Karina Nowakowska, MD
The Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Poland.
- 01
During a depressive episode, the individual experiences consistently depressed mood, which is not in line with their circumstances. This low mood persists for most of the day, nearly every day, and is not significantly influenced by external events. This state of low mood must persist for at least 2 weeks and cannot be attributed to the effects of a substance or another medical condition.
In order to diagnose an episode of depression, at least five of the followin symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either depressed mood or loss of interest or pleasure. Markedly diminished interest or pleasure in all, or almost all activities. Experiencing significant weight loss without dieting, or weight gain, along with changes in appetite, insomnia or excessive sleep. Others may notice observable restlessness or slowing down of movements. Feeling tired, worthless, or excessively guilty, and having difficulty concentrating or making decisions. Also, having recurrent thoughts of death, suicidal ideation, or attempts at suicide. The symptoms cause significant distress or impact in social, work, or other important areas of life.
When differentiating between grief and a major depressive episode (MDE), it's important to consider the following distinctions: In grief, the primary emotional experience is feelings of emptiness and loss, while in MDE, there is a persistent depressed mood and the inability to look forward to happiness or pleasure. The distress in grief usually lessens over time, typically over days to weeks and occurs in waves, often triggered by thoughts or reminders of the deceased. On the other hand, the depressed mood in MDE is more enduring and not linked to specific thoughts or concerns. Grief may be punctuated by positive emotions and humor, which are atypical of the constant unhappiness and misery associated with MDE. In grief, there may be a preoccupation with thoughts and memories of the deceased, rather than the self-critical or pessimistic ruminations found in MDE. Self-esteem is generally maintained in grief, whereas in MDE, feelings of worthlessness and self-loathing are common. If bereaved individuals think about death and dying, their thoughts are usually focused on the deceased, possibly about "joining" the deceased. On the other hand, in MDE, such thoughts are focused on ending one's own life due to feeling worthless, undeserving of life, or unable to cope with the pain of depression.
- 02
Psychotherapy involves treating psychiatric and behavioral disorders through communication based on a psychological model of illness. It starts with a patient seeking relief from current symptoms or prevention of their recurrence. Different types of psychotherapy, such as cognitive behavioral therapy or interpersonal therapy, can be effective for treating depression. Mental health professional may also suggest other types of therapies.
Pharmacotherapy focuses on the brain circuitry that regulates mood. The three key chemicals involved are norepinephrine, serotonin, and dopamine. Research indicates that in depression, the brain circuits that utilize these chemicals are not functioning properly. Antidepressants adjust these chemicals to improve the functioning of the circuits, which can help enhance mood.
In Electroconvulsive Therapy (ECT), electrical currents are passed through the brain to impact the function and effect of neurotransmitters, relieving depression. ECT is typically used for individuals who do not respond to medications, are unable to use antidepressants due to health issues, or are at significant risk of suicide.
TMS, or transcranial magnetic stimulation, could be considered for individuals who have not had success with antidepressants. Throughout TMS, a treatment coil is positioned on your scalp to deliver brief magnetic pulses, thereby activating nerve cells in the brain responsible for mood regulation and depression. This action creates a magnetic field that generates an electric current, stimulating nerve cells in the prefrontal cortex of the brain, an area crucial for mood control.
- 03
Treatment recommendations for depression vary depending on its severity. Guidelines suggest that mild depression may improve with exercise or waiting it out, but psychotherapy or antidepressants could be considered if initial efforts are ineffective. For moderate major depression, first-line treatments include antidepressant monotherapy, psychotherapy, or a combination of both. Combined treatment is more effective than medication alone. Severe depression may require antidepressants combined with antipsychotic medication, electroconvulsive therapy, or a combination of antidepressants and psychotherapy. Cognitive-behavioral Therapy (CBT) and Interpersonal Therapy (IPT) are the most supported methods, both in acute and maintenance phases of MDD, and have been studied in combination with antidepressants. Antidepressants should ideally be accompanied by psychological interventions, and treatment methods should be personalized based on individual needs and preferences.
- 04
It's crucial to remember that people with depression are at a higher risk of experiencing more illnesses throughout their lives compared to the general population. Unfortunately, they are also more likely to go untreated, which increases the risk of death from undiagnosed and untreated illnesses such as cancer, diabetes, heart disease, or HIV by 40-60%. Depression and anxiety significantly increase the likelihood of heart attack and stroke, and the reluctance to undergo tests and treatment further complicates the situation. Patients with mood disorders tend to lead less active lifestyles, pay less attention to the nutritional value of their food, and often consume unhealthy high-calorie, high-carbohydrate, and high-fat foods. These factors can lead to obesity, hypertension, diabetes, and atherosclerosis, which are often referred to as silent killers due to their long-term impact on life quality and expectancy. Additionally, people with depression may have reduced willpower in fighting illnesses, including cancer, which affects their chances of recovery, as anticancer therapy is often undertaken only in the advanced stages of the disease for these individuals.
The psychological effects of untreated depression are far-reaching and include:
- Increased risk of recurring depressive episodes
- Development of anxiety disorders, primarily generalized anxiety disorder
- Personality changes such as deepening hypochondriac, hysterical, and anankastic features
- Persistent sexual disorders
- Psychosomatic complaints, such as headaches, stomach aches, or chest pains that persist for a long time, occurring without specific causes, but causing increasing anxiety and intensifying the depressive state
- Reduced effectiveness of tasks performed, leading to deterioration in academic performance and work efficiency
- Progressive social alienation
-The most direct of the tragic effects of untreated depression are suicide attempts.
- 05
Depression and anxiety disorders are prevalent in both the community and in primary care settings. Individuals with depression often exhibit symptoms of anxiety disorders, and conversely, those with anxiety disorders frequently also experience depression. It can be challenging to differentiate between the two, but it is crucial to recognize and address both conditions, as they are linked to significant levels of illness and death. About 85% of individuals with depression also encounter significant symptoms of anxiety, while comorbid depression is present in up to 90% of individuals with anxiety disorders. As many as 25% of patients in general practice have both anxiety and depression. The co-occurrence of anxiety and depression is primarily attributed to a shared genetic predisposition to both conditions or one disorder being a secondary outcome of the other. Both depression and specific anxiety disorders necessitate suitable treatment. Psychological interventions such as cognitive behavioral therapy, antidepressants, and occasionally antipsychotics have demonstrated effectiveness in addressing both depression and anxiety. The combination of anxiety and depression intensifies the severity, raises the risk of suicide, increases disability, and makes treatment less effective. Moreover, the combined conditions lead to more profound psychological, physical, social, and workplace impairment compared to either disorder alone.
Recent evidence indicates that bipolar disorder may be more prevalent than previously believed, with experts in the field suggesting rates of 5% to 7%. There is compelling evidence that bipolar disorder is often either overlooked or misdiagnosed as major depressive disorder. The most common misdiagnosis is major depressive disorder, occurring in 60% of cases. Patients with bipolar disorder often initially present with depressive episodes. Up to 35% to 60% of patients experience a major depressive episode before experiencing a manic episode. Additionally, patients tend to downplay their experience of hypomanic episodes, contributing to misdiagnosis as depression. Antidepressants have been associated with adverse outcomes in patients with bipolar disorder; misdiagnosis of depression and treatment with antidepressants put approximately 30% to 40% of bipolar patients at risk of inducing manic episodes. Patients with bipolar disorder who take antidepressants also have an increased risk of rapid cycling. Current guidelines recommend prescribing antidepressants alongside a mood stabilizer for patients with bipolar disorder. Misdiagnosis and inappropriate treatment of patients with bipolar disorder also delay the use of mood stabilizers and may increase the risk of treatment resistance as more episodes are experienced. There is also evidence that appropriate treatment of bipolar disorders can reduce suicide risk and that earlier recognition and treatment of bipolar disorders in children and adolescents can reduce subsequent risk of substance abuse.
The connection between depression and dementia is intricate and not yet fully understood. There are various perspectives on how these two conditions are related and the underlying neurobiological mechanisms involved. In general, there is compelling evidence supporting the idea that depression in early life can increase the risk of developing dementia later in life and that depression in later life can be an early sign of dementia. Additionally, there is evidence indicating that both conditions exhibit similar neurobiological changes, particularly in white matter disease, suggesting shared risk factors or a common pattern of neuronal damage. These findings emphasize the need to investigate whether effectively treating depressive episodes can reduce the prevalence of dementia. It is also important for clinicians to be attentive to late-life depression as a potential early stage of dementia development and to carefully monitor these individuals for future cognitive impairment.
- 06
Such changes can encompass physical activity, dietary choices, spending time outdoors, nurturing relationships, engaging in leisure activities, practicing relaxation techniques, managing stress, incorporating spirituality, and helping others.
Exercise. Engaging in regular physical activity can be just as effective in addressing depression as taking medication. Exercise not only increases the levels of serotonin, endorphins, and other mood-enhancing brain chemicals, but also stimulates the generation of new brain cells and connections, similar to the way antidepressants work. Even a 30-minute walk each day can have a significant impact. To achieve optimal outcomes, strive for 30 to 60 minutes of aerobic exercise on a regular basis.
Nutrition. Maintaining a nutritious diet is crucial for your physical and mental well-being. Consuming small, balanced meals at regular intervals can help sustain your energy levels and reduce fluctuations in mood. Even though you might be tempted to reach for sugary snacks for a rapid energy increase, opting for complex carbohydrates is a more beneficial decision. They will provide sustainable energy without the subsequent sugar crash.
Sleep. The amount of sleep you get can significantly impact your mood. Inadequate sleep can worsen symptoms of depression. Lack of sleep can intensify feelings of irritability, mood swings, gloominess, and exhaustion. It's important to ensure you achieve a sufficient amount of sleep every night. Few individuals function optimally with less than seven hours of sleep each night. Strive to get between seven to nine hours of sleep per night.
Social support. Remember to stay connected with friends and family regularly since having strong social connections can decrease feelings of isolation, which is a significant risk factor for depression. You might also want to think about participating in a class or group as another way to maintain social connections.
Stress reduction. Adjust your life to cope with and lessen stress. Excessive stress worsens depression and increases the likelihood of future depression. Identify the elements of your life that cause stress, like an overwhelming workload or unsupportive relationships, and discover ways to reduce their influence.
- 07
Unipolar depression is twice as common among women in their fertile years compared to men. Current biological theories suggest that stages of life with declining levels of estrogen could trigger depression. Psychological theories point to low self-esteem, sensitivity to lack of social support, comorbidity with anxiety, and inward aggression in women, and outward aggression and comorbidity with alcohol abuse in men. Social theories highlight the preponderance of women in poverty and economic dependence.
The most consistent finding in the study of major depressive disorder is that it is more prevalent in females. However, there are no clear differences between genders in terms of symptoms, course, treatment response, or functional consequences. Suicide is a greater risk for men and increases with age, while suicide attempts are more common in women and decrease with age.
When choosing treatment, it's crucial to consider whether a woman is planning a pregnancy, as it significantly influences the choice of treatment method. In such cases, psychotherapy is recommended as the first line of treatment. If pharmacotherapy is necessary or preferred by the patient, the doctor selects a drug that is safe during pregnancy.
Sexual dysfunction is a common and potentially distressing side effect of antidepressants that affects both men and women, leading to non-adherence to medication. The management of antidepressant-induced sexual dysfunction requires an individualized approach, such as considering other causes, dose reduction, adding medication to treat the adverse effect, or switching to a different antidepressant.

Panos Zanos, Ph.D.
Assistant Professor
Director, Translational Neuropharmacology Lab
Department of Psychology
University of Cyprus

- 01
Depression is a complex condition influenced by both genetic and environmental factors. Studies involving twins and families suggest that depression has a genetic component, with heritability estimates ranging from 30% to 50%. This indicates that while genetics play a significant role, they do not comprise the only vulnerability factor. Environmental influences such as trauma (perhaps childhood trauma) or chronic stress also contribute to the risk. It's essential to understand that having a genetic predisposition to depression does not mean that the individual or their family will definitely develop the disorder. Epigenetic changes, i.e., alterations in gene expression emerged and triggered by lifestyle and life experiences can also highly impact the risk for developing depression.
- 02
Neurotransmitters are chemicals that transmit signals between neurons, usually within synapses, in the brain, playing crucial roles in regulating mood, sleep architecture, cognitive functions and other behaviors. In depression, imbalances in neurotransmitters like serotonin and/or dopamine are traditionally believed to contribute to symptoms. Serotonin is associated with mood regulation, and lower levels of this neurotransmitter have been linked to lower mood. Dopamine is related to motivation and pleasure. A dysregulation in the dopaminergic system can lead to anhedonia (lack of feeling pleasure) and reduced motivation, behaviors commonly observed in depression. Classical, monoamine-based antidepressant medications target these neurotransmitter systems. For example, Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine and sertraline increase serotonin levels in the brain by blocking its reuptake, while serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) like venlafaxine work by blocking reuptake of both serotonin and norepinephrine. Dopamine-targeting medications, such as bupropion, inhibit dopamine reuptake, thus increasing extracellular dopamine levels to help with anhedonia symptoms of depression. While neurotransmitter imbalances are a key focus in the field of depression, the disorder involves a way more complex neurobiology, including neuroplasticity, inflammation, and stress response mechanisms.
- 03
Treatment-resistant depression (TRD) emerges when an individual who suffers with major depression does not respond adequately to at least two different antidepressant treatments. This reflects the complex and varied neurobiology of depression. Classical antidepressants typically target monoamine neurotransmitters (serotonin, dopamine, norepinephrine), but in TRD, other factors like glutamatergic signaling, impaired neuroplasticity, chronic inflammation, or hypothalamic-pituitary-adrenal (HPA) axis impairment may play a major role as well. During the last decades, novel strategies have been explored to address TRD. Ketamine, an anesthetic medication, shows promise by rapidly altering glutamate signaling and enhancing neuroplasticity, which are largely impaired in depresion. Although NMDA receptor inhibition was believed to be the main mechanism underlying this rapid action of ketamine to relief depression, new findings challenge this hypothesis. Other drugs, such as esketamine, a racemic ketamine enantiomer has been recently approved by the FDA and EMA for the trearment of depression. Additionally, the opioid system is being investigated with drugs like buprenorphine, which may restore opioid dysfunction that has been also linked to depression. Neuromodulation techniques, such as repetitive transcranial magnetic stimulation (rTMS) and deep brain stimulation (DBS), have also been tested for depression treatment and aim to directly alter neural circuit activity. Personalized approaches, including pharmacogenetic testing, are increasingly used to tailor treatments based on an individual's genetic profile, improving the prospect of finding next-generation effective interventions for TRD.
- 04
Genetic and epigenetic factors significantly influence how individuals respond to antidepressant medications; This field of study is widely known as pharmacogenomics. Genetic variations in enzymes like cytochrome P450 (CYP450) influence drug metabolism. For example, variations in CYP2D6 and CYP2C19 genes have been shown to impact the effectiveness and side effects of many classical, monoamine-based antidepressants. Polymorphisms in genes encoding drug targets, such as the serotonin transporter (SLC6A4) and serotonin receptors (HTR2A), were also reported to influence treatment response. Epigenetic modifications, which alter gene expression without changing DNA sequences, are highly influenced by environmental factors ranging from stress, diet, as well as early life experiences. These modifications can affect the expression of genes involved in neurotransmitter signaling, neuroplasticity, and stress response, thus indirectly influencing therapeutic outcomes. Personalized medicine aims or should aim to use genetic and epigenetic details to tailor treatment plans. Pharmacogenetic testing can guide medication selection and dosing, reducing trial-and-error approaches and minimizing adverse effects. Research into identifying novel epigenetic biomarkers is ongoing, with the potential to predict treatment response and guide the selection of the appropriate interventions, including pharmacotherapies and/or psychotherapies. Personalized medicine is poised to improve treatment outcomes by integrating genetic, epigenetic, clinical and pre-clinical data for more precise and effective care.

Grigoriou Od. Vasileios, PhD
Psychiatrist - Consultant, Psychiatric Hospital of Attika (DAFNI)
- 01
These strategies can be tailored to the individual's preferences and needs, and it's often helpful for patients to try a combination of different approaches to see what works best for them. Additionally, regular follow-up with a mental health professional can ensure that the coping mechanisms are effective and provide an opportunity to adjust the treatment plan as needed.
1.Mindfulness and Meditation:
• Mindfulness Practices: Techniques such as mindfulness meditation can help patients stay present and reduce stress.
• Breathing Exercises: Simple deep breathing exercises can help calm the mind and body.
2. Physical Activity:
• Exercise: Regular physical activity, even something as simple as a daily walk, can improve mood and reduce symptoms of depression.
• Yoga: Combines physical movement, meditation, and breathing exercises to help reduce stress and improve mental well- being.
3. Healthy Lifestyle Choices:
• Sleep Hygiene: Maintaining a regular sleep schedule and creating a restful sleep environment can significantly impact mood.
• Balanced Diet: Eating a nutritious diet can improve overall physical health and mood.
4. Social Support:
• Connecting with Others: Spending time with friends and family, or joining support groups, can provide emotional support.
• Therapy: Regular sessions with a therapist can help patients process their feelings and develop coping strategies.
5. Cognitive Behavioral Techniques:
• Challenging Negative Thoughts: Techniques from cognitive behavioral therapy (CBT) can help patients identify and reframe negative thinking patterns.
• Journaling: Writing about thoughts and feelings can help patients process emotions and gain perspective.
6. Structured Routine:
• Daily Schedule: Keeping a structured daily routine can provide a sense of normalcy and purpose.
• Goal Setting: Setting small, achievable goals can help patients feel a sense of accomplishment.
7. Limiting Alcohol and Avoiding Drugs:
• Substance Use: Avoiding alcohol and recreational drugs can prevent exacerbation of depression symptoms.
8. Seeking Professional Help:
• Medication: For some patients, medication prescribed by a psychiatrist can be crucial in managing symptoms.
• Emergency Contacts: Having a plan for crisis situations, including knowing who to contact and where to go for immediate help.
9. Engaging in Activities:
• Hobbies and Interests: Engaging in activities that the patient enjoys can provide a distraction and lift their mood.
• Volunteering: Helping others can improve self-esteem and provide a sense of purpose.
10. Self-Compassion:
• Being Kind to Oneself: Encouraging patients to be gentle with themselves and recognize that it’s okay to have difficult days.
- 02
Determining the appropriate dosage of antidepressant medication involves a careful and individualized approach, influenced by a variety of factors. The primary consideration is the diagnosis and severity of the patient’s depression. For instance, the treatment strategy can differ significantly based on whether the patient is dealing with major depressive disorder, dysthymia, or another depressive condition. The intensity and duration of symptoms are also crucial in guiding both the starting dose and any necessary adjustments.
The patient’s medical history plays a significant role in this process. A comprehensive review of their past medication use, including their response to previous antidepressants and any history of side effects or adverse reactions, provides valuable insights. Additionally, co-existing medical conditions, such as liver or kidney disease, cardiovascular issues, or other health problems, can affect how the body metabolizes medication, necessitating dose adjustments to avoid complications.
Age and weight are other critical factors in determining the appropriate dosage. For instance, older adults often require lower doses due to changes in metabolism and increased sensitivity to medications. Similarly, the patient’s body weight can influence the dosage needed to achieve the desired therapeutic effect. Genetic factors, such as pharmacogenetics, can sometimes predict how a patient will respond to certain medications, helping to tailor the dosage more precisely.
Drug interactions must also be carefully considered. The potential for interactions with other medications the patient is taking can impact the effectiveness and safety of the antidepressant, making it essential to evaluate the entire medication regimen. The side effect profile of the chosen antidepressant is another key factor. The patient's ability to tolerate potential side effects can influence the choice of medication and the initial dosage, aiming to minimize discomfort while maximizing efficacy.
The patient's lifestyle and preferences are integral to the decision-making process. Simplifying the medication regimen to enhance adherence, such as opting for once-daily dosing, can be beneficial. Additionally, considerations about the patient's daily routine and the potential impact on sleep or energy levels can guide the choice of medication and dosage.
Clinical guidelines and evidence-based practices are fundamental in determining the starting doses and titration schedules. These guidelines are based on extensive research and clinical trials, providing a framework for safe and effective treatment. The typical process involves an initial comprehensive assessment of the patient’s symptoms and medical history, starting with a low dose to minimize side effects, especially in sensitive populations like the elderly or those with comorbid conditions. Regular monitoring and adjustment are crucial, as antidepressants can take several weeks to show their full effects. Adjustments are made based on the patient’s response and tolerance, with changes typically occurring every few weeks.
Continuous assessment of symptom improvement and side effects is vital, ensuring that the treatment remains effective and well-tolerated. Collaboration with the patient is essential to address any concerns and ensure adherence to the prescribed regimen. Long-term management involves maintaining regular follow-ups to monitor ongoing efficacy and any emerging side effects, with periodic reassessment to determine the need for continuation, dosage adjustments, or switching medications if necessary.
This individualized approach helps ensure that each patient receives the most effective and well-tolerated treatment for their depression, optimizing outcomes and enhancing overall well-being.
- 03
Managing the stigma associated with depression, particularly in social or work environments, can be challenging but is essential for a patient's well-being. Here are some strategies that can help:
Firstly, educating oneself about depression is crucial. Understanding the nature of the illness can help patients feel more confident in discussing it and reduce feelings of shame or embarrassment. Knowledge is empowering and can equip patients with the facts needed to correct misconceptions about depression. Open communication is another key strategy. Sharing one’s experience with trusted friends, family members, or colleagues can foster understanding and support. It can be helpful to explain that depression is a medical condition, not a personal weakness, and that seeking treatment is a proactive step towards recovery. Being selective about whom to confide in can ensure that the patient receives a supportive and empathetic response.
Seeking support from mental health professionals, such as therapists or counselors, can provide a safe space to discuss feelings and challenges without fear of judgment. These professionals can also offer practical advice on managing stigma and navigating social or work environments.
Joining a support group, either in person or online, can also be beneficial. Connecting with others who have similar experiences can reduce feelings of isolation and provide a sense of community. Support groups can be a source of encouragement and practical tips for dealing with stigma.
In the workplace, it can be helpful to discuss any necessary accommodations with a supervisor or HR representative. Explaining how depression affects work performance and requesting reasonable adjustments, such as flexible working hours or a reduced workload during particularly challenging periods, can make a significant difference. It’s important to frame these requests in terms of how they will help improve job performance and overall productivity.
Fostering a supportive work environment can also involve educating colleagues about mental health. Many workplaces offer mental health training or awareness programs that can help reduce stigma. Encouraging participation in these programs can promote a more understanding and supportive workplace culture.
Practicing self-compassion is crucial for managing stigma. Patients should remind themselves that depression is a common and treatable condition, and that seeking help is a sign of strength. It’s important to avoid self-blame and to treat oneself with kindness and understanding, recognizing that everyone faces challenges and that it’s okay to need support.
Engaging in self-care activities that promote well-being can also help mitigate the impact of stigma. Regular physical activity, healthy eating, adequate sleep, and mindfulness practices can improve overall mental health and resilience. Maintaining hobbies and interests can provide a sense of normalcy and fulfilment.
Finally, advocating for mental health awareness can empower patients and contribute to reducing stigma on a broader scale. Speaking out about personal experiences, when comfortable, and participating in mental health campaigns or initiatives can help change public perceptions and promote understanding.
By using these strategies, patients can better manage the stigma associated with depression, fostering a more supportive and understanding environment both socially and at work.
- 04
The treatment landscape for depression in Greece and Europe has evolved significantly with improved access to a range of therapies including psychotherapy, pharmacotherapy, and community-based services. Despite these advancements, challenges persist, particularly in rural areas where access to specialized care remains limited, contributing to long wait times and disparities in service availability. Stigma surrounding mental health continues to deter individuals from seeking help, necessitating further public education efforts to promote awareness and reduce discrimination. Enhancing integration of mental health services within primary care systems, expanding support systems and rehabilitation services, and investing in digital health technologies are crucial steps forward. Continued efforts to address these areas will be essential in ensuring comprehensive and equitable mental health care for all individuals affected by depression across Greece and Europe.